Pharmacogenomics in Drug Metabolism & Kidney Function

Explore how genetic differences affect renal drug metabolism, particularly in managing comorbidities like hypertension and diabetes in CKD patients. Gain practical knowledge in integrating genomics into daily practice. Learn how variations in genes encoding cytochrome P450 enzymes influence drug dosing and toxicity. Understand the pharmacogenomic considerations in prescribing ACE inhibitors, ARBs, and antidiabetic medications in renal impairment. Discover how personalized medicine can minimize adverse drug reactions and improve therapeutic outcomes. Review current guidelines and decision-support tools for pharmacogenomic testing in nephrology. Examine case-based scenarios illustrating the clinical utility of genomic profiling in complex renal patients.

    Related Conference of Pharmacogenomics in Drug Metabolism & Kidney Function

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Pharmacogenomics in Drug Metabolism & Kidney Function Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in